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Background and purpose   Customized femoral stems are designed 
to have a perfect fit and fill in the femur in order to achieve physi-
ological load transfer and minimize stress shielding. Dual-energy 
X-ray absorptiometry (DXA) is regarded as an accurate method 
for detection of small alterations in bone mineral density (BMD) 
around hip prostheses. We present medium-term DXA results 
from a randomized study comparing a customized and an ana-
tomical femoral stem.
Methods   100 hips were randomized to receive either the ana-
tomical ABG-I stem or the Unique customized femoral stem, both 
uncemented. DXA measurements were conducted postoperatively 
and after 3, 6, 12, 24, 36, and 60 months, and BMD was computed 
for each of the 7 Gruen zones in the proximal femur.
 Results   Results from 87 patients were available for analysis. 
78 completed the 5-year follow-up: 35 patients in the ABG group 
and 43 patients in the Unique group. In both groups, we found 
the greatest degree of bone loss in the proximal Gruen zones. In 
zone 1, there was 15% reduction in BMD in the ABG-I group and 
14% reduction in the Unique group. In zone 7, the reduction was 
28% in the ABG-I group and 27% in the Unique group. The only 
statistically significant difference between the groups was found 
in Gruen zone 4, which is distal to the tip of the stem, with 1.6% 
reduction in BMD in the ABG-I group and 9.7% reduction in the 
Unique group (p = 0.003).
Interpretation   5-year DXA results showed that because of 
stress-shielding, proximal bone loss could not be avoided—either 
for the anatomical ABG-I stem or for the customized Unique stem. 
 
Implantation of a prosthesis in the femur alters the load distri-
bution in the host bone, and the femur remodels to adapt to the 
new mechanical situation (Engh and Bobyn 1988, Bobyn et al. 
1992, Engh et al. 1999). A perfect fit and fill in the proximal 
femur is said to be important to achieve physiological load 
transfer (Laine et al. 2000). It has therefore been hypothesized 
that a customized femoral stem could fulfill the criterion for 
optimal fit and fill, and thus minimize stress shielding in the 
proximal femur (Bargar 1989). Based on numerical analyses, 
however, it has been claimed that canal-filling femoral stems 
may cause stress shielding and subsequently bone atrophy of 
the proximal femur (Huiskes et al. 1989). 
In vitro studies on human cadaver femurs have indicated 
that insertion of a customized stem gives a better pattern and 
distribution of cortical strains in the proximal femur than ana-
tomical stems (Aamodt et al. 2001, Østbyhaug et al. 2009). In 
these studies, it was shown that 33–56% of the external corti-
cal strains were retained on the proximal, medial aspect of the 
femur after insertion of a customized stem whereas the cor-
responding figure was 10–13% after insertion of a standard, 
anatomical stem. Long-term bone remodeling is, however, not 
necessarily reflected in the immediate postoperative mechani-
cal situation in the femur as measured in experimental strain 
analyses. 
The present randomized, clinical study was undertaken to 
compare (by DXA) the medium-term changes in bone min-
eral density in the proximal femur after insertion of an unce-
mented, customized femoral stem and an uncemented, stand-
ard anatomical femoral stem. 
Patients and methods
Patients less than 65 years of age with primary osteoarthritis 
or secondary osteoarthritis due to hip dysplasia, Legg-Calve-
Perthes disease, trauma, or avascular femoral head necrosis 
were eligible for inclusion. Patients with abnormal size and 
geometry of the proximal femur, who were considered unsuit-Acta Orthopaedica 2011; 82 (4): 410–416  411
able  for  a  standard  femoral  prosthesis,  were  excluded. All 
patients signed an informed consent form and the study was 
approved by the Regional Ethics Committee (No. 70-98). The 
study was conducted according to the requirements of the Hel-
sinki Declaration. 
We enrolled 100 hips in the study (Figure 1). The inclu-
sions were done between January 1999 and April 2001. Non-
computerized randomization, in blocks of 10, was carried out. 
The code was kept in a sealed, opaque envelope and it was 
broken at the outpatient clinic after the patients had signed the 
informed consent form. 50 hips were scheduled to receive a 
Unique uncemented, customized femoral stem (SCP, Trond-
heim, Norway) and 50 hips were scheduled to receive the 
uncemented, anatomical ABG-I (Stryker-Howmedica, Allen-
dale,  NJ).  Due  to  a  manufacturing  time  of  4–6  weeks  for 
the customized prostheses, randomization took place during 
a preoperative outpatient visit and 2 patients randomized to 
the ABG-I group withdrew from the study due to delay of the 
operation. 6 patients were excluded due to inadequate post-
operative DXA measurements. 5 patients with bilateral hip 
replacements  were  originally  included.  Later,  the  first  hip 
to be operated in each of these patients was excluded from 
the study to maintain independence of data. Results from 87 
patients were available for analysis; 78 of these patients com-
pleted the 5-year follow-up—35 patients in the ABG-I group 
and 43 patients in the Unique group. 
31 men and 56 women were included; the mean age was 
53 (21–65) years in the ABG-I group and 55 (36–65) years 
in the Unique group (Table 1). The diagnoses were primary 
osteoarthritis (49), dysplasia of the hip (29), Legg-Calve-Per-
thes disease (4), posttraumatic osteoarthritis (3), and avascular 
necrosis (2).
After  5  years,  no  hips  had  been  revised  but  5  patients 
reported complications. In the ABG-I group 2 patients had an 
early dislocation, 1 patient developed a deep venous thrombo-
sis, and 1 had an episode of subluxation. In the Unique group, 
1 patient suffered from an intraoperative injury of the common 
peroneal nerve. 
Implants
Both  stems  are  made  of  titanium  alloy  (Ti6Al4Va)  with 
hydroxyapatite coating (HA), and they have a modular femo-
ral head and no collar (Figure 2). The design of the Unique 
customized stem is based on 2-D, cross-sectional CT scans 
Table 1. Study samples
  ABG-I  Unique
  femoral stem  femoral stem
No. of patients  41  46
No. of females / males  28 / 13  28 / 18
Primary ostearthrtitis  49%  63%
Hip dysplasia  44%  24%
Sequelae: Perthes’ disease    2%    7%
Posttraumatic    2%    4%
Avascular femoral head necrosis    2%    2%
Figure 1. Consort flow chart.
Assessed for eligibility
(n = 100)
ABG
Allocated  to intervention
(n = 48)
Unique
Allocated  to intervention
(n = 50)
Randomized
(n = 100)
Analyzed
(n = 35)
Analyzed
(n = 41)
Analyzed
(n = 43)
Analyzed
(n = 46)
Excluded (n = 2)
– no operation(n = 2)
Lost to follow-up 
baseline (n = 4)
– missing posoperative
   DXA results (n = 2)
– bilateral hip (n = 2)
Lost to follow-up 
baseline (n = 7)
– missing posoperative
   DXA results (n = 4)
– bilateral hip (n = 3)
Lost to follow-up 
5 years (n = 6)
– technical error (n = 2)
– drop-out (n = 4)
Lost to follow-up 
5 years (n = 3)
– technical error (n = 2)
– dead (n = 1)
Figure 2. The implants. The Unique stem (left) and the ABG-I (right).412  Acta Orthopaedica 2011; 82 (4): 410–416
of the proximal femur. Using an interactive design algorithm, 
closed contours were generated along the corticocancellous 
interface of the femoral canal. It has been shown that a CT 
density of 600 Hounsfield Units (HU) represents this interface 
(Aamodt et al. 1999). The stems were designed to fit closely 
to the inner cortical surface in the metaphyseal region in order 
to  obtain  maximum  mechanical  stability  and  optimal  load 
transfer. The stem has a circumferential plasma-sprayed HA 
coating of 50 µm thickness and 62% crystallinity on its proxi-
mal two-thirds. The distal third is unpolished and has a rough-
ness of 2.5 µm. It is downscaled to prevent distal locking and 
load transfer. A resection guide mounted on an intramedul-
lary reamer was used to achieve the preplanned resection level 
on the femoral neck. The femoral canal was prepared using a 
custom-made broach that had the same dimensions as those of 
the prosthesis, except that its diameter was 1 mm larger distal 
to the coating area. No diaphyseal reaming was performed. 
The ABG-I stem is an anatomical stem with a press-fit meta-
physeal fixation. At the metaphyseal level, the prosthesis is 
covered with a plasma-sprayed HA layer with a thickness of 60 
µm and a crystallographic composition of 98–99% (Giannikas 
et al. 2002). The coating area has a macro relief scaled surface 
were clinically assessed using the Merle d’Aubigne (MdA) 
score for measurement of pain, joint mobility, and ability to 
walk (d’Aubigne and Postel 1954).
Bone densitometry
To evaluate changes in bone mass, the patients were exam-
ined using a Hologic QDR 4500 DXA scanner (Hologic Inc., 
Bedford, MA) within the first week and after 3, 6, 12, 24, 36, 
and 60 months. Scanning was performed with the patient in 
supine position. The leg was placed in a standardized support 
to ensure a neutral position. Bone mineral density (BMD) in 
the frontal plane of the femur was measured according to the 
7 Gruen zones. Figure 3 shows the anatomical landmarks that 
divide the zones; in the horizontal plane, the tip of the lesser 
trochanter defines the distal border of zones 1 and 7. The mid-
point between the lesser trochanter and the tip of the stem 
defines the border between zones 2 and 3, and 5 and 6. Zone 
4 represents the total bone area 20 mm distally from the tip of 
the stem. Vertically, the center axis of the femur divides the 
medial and lateral zones. Postoperative measurements were 
used as baseline values. 
designed to transform shear forces 
into  compression  forces  (Tonino 
et al. 1995). The distal portion of 
the  implant  is  designed  to  avoid 
endomedullary  contact  with  the 
diaphysis (Panisello et al. 2009b). 
Before implantation of the ABG-I 
stem, the medullar canal was pre-
pared  with  1  mm  over-reaming, 
and then sequential rasping of the 
metaphysis was performed. 
Stem size and neck resection was 
decided by preoperative and intra-
operative planning. On the acetab-
ular side, we used an uncemented 
Duraloc  component  (DePuy, 
Leeds,  UK),  except  for  2  cases, 
which were operated with autolo-
gous impaction bone grafting and 
a  cemented  Elite  plus  Ogee  cup 
(DePuy). Both patients were in the 
Unique group. Postoperatively, the 
patients were allowed full weight 
bearing  with  2  crutches  for  two 
months.  Antibiotic  prophylaxis 
was  given  for  the  first  24  h  and 
low-molecular-weight  heparin  for 
the first 14 days. 
4  experienced  orthopedic  sur-
geons  performed  all  the  proce-
dures and a standard direct lateral 
approach  was  used.  The  patients 
Figure  3.  Average  bone 
mineral  density  (%,  with 
95%  CI)  in  the  7  Gruen 
zones  from  baseline  to 
5-year follow-up. Acta Orthopaedica 2011; 82 (4): 410–416  413
Statistics
Our main aim was to evaluate changes in bone density around 
2 uncemented hip arthroplasties and to compare the groups 
after 5 years. The BMD measurements were normally distrib-
uted. Comparison of data between the groups was carried out 
using an independent-samples Student t-test procedure. Base-
line results were compared to subsequent measurements with a 
paired Student’s t-test. Postoperative measurements were used 
as baseline values and the measurements at follow-up were 
expressed as a percentage of the baseline measurements. Due 
to multiple comparisons, the significance level was adjusted to 
p ≤ 0.007 according to the Bonferroni correction.
Results
The mean relative changes in BMD (Tables 2 and 3), for each 
of the 7 Gruen zones from baseline to 5 years, were plotted 
separately for both arthroplasties (Figure 3). There was no 
significant difference in baseline global BMD between the 
groups (p = 0.9). After 5 years, we measured a global BMD 
loss of 7.7% in the ABG-I group and 11% in the Unique group 
(p = 0.09). When we compared baseline DXA values in each 
Gruen zone, we found significant changes in zones 1, 6, and 7 
(p < 0.005) between the stems. In the ABG-I group, we noted 
a reduction in BMD in all Gruen zones except zone 5. There 
were significant changes in zones 1, 2, 6, and 7 (p < 0.001) 
when comparing the changes in BMD from baseline to 5-year 
follow-up. Bone loss was greatest in proximal zones 1 and 7. 
In Gruen zone 1, in the ABG-I group, there was a 14% reduc-
tion in BMD after 2 years and a further decrease to 15% after 5 
years. The greatest decline in BMD was found in Gruen zone 
7. After 2 years there was a 22% reduction in BMD, and a 
further loss up to 28% after 5 years. 
The trend was similar in the Unique group, where we found 
significant differences in BMD in Gruen zones 1, 2, 3, 4, and 7 
after 5 years compared to baseline measurements (p < 0.001). 
In zone 1, there was 13% loss after 2 years—increasing to 
14% after 5 years. In zone 7, the decrease was 24% after 2 
years and 28% after 5 years. In the middle areas (in zones 2, 3, 
5, and 6) there were only small changes in BMD from 2 to 5 
years in both groups. Implantation of a femoral stem affected 
the BMD in zone 5 to a small extent. There was full recov-
ery in bone density around both stems after 1 year, and the 
bone mineral density was unaltered after 5 years. In the distal 
area (zone 4), we found a significant difference between the 
groups at 5 years. There was only a slight reduction in bone 
mineral density of 1.6% in the ABG-I group as compared to 
9.9% reduction in BMD in the Unique group (p = 0.003). In all 
other zones, we found no statistically significant differences in 
BMD between the two groups.
The clinical scores were similar between the groups, both 
preoperatively and at 5 years. The mean preoperative Merle-
d’Aubigne score was 11 (7–14) in the ABG-I group and 10 
(6–13) in the Unique group. The mean scores after 5 years 
were 17 in both groups. 
Table 2. Mean (SD) values of BMD (in g/cm²) in the 7 Gruen zones from baseline to 5 years in the ABG-I group
Gruen zone  Baseline  3 months  6 months  12 months   24 months  36 months  60 months
1  0.78 (0.1)  0.68 (0.1)  0.67 (0.13)  0.67 (0.13)  0.67 (0.14)  0.67 (0.15)  0.66 (0.15)
2  1.52 (0.26)  1.44 (0.29)  1.42 (0.28)  1.42 (0.29)  1.43 (0.27)  1.43 (0.24)  1.40 (0.26)
3  1.64 (0.26)  1.55 (0.24)  1.58 (0.21)  1.58 (0.19)  1.59 (0.21)  1.58 (0.19)  1.60 (0.22)
4  1.73 (0.22)  1.68 (0.23)  1.70 (0.22)  1.74 (0.22)  1.73 (0.22)  1.73 (0.22)  1.71 (0.24)
5  1.63 (0.23)  1.58 (0.26)  1.61 (0.25)  1.66 (0.23)  1.66 (0.23)  1.66 (0.23)  1.65 (0.24)
6  1.43 (0.27)  1.31 (0.26)  1.34 (0.25)  1.34 (0.22)  1.33 (0.24)  1.32 (0.23)  1.32 (0.27)
7  1.22 (0.28)  1.03 (0.25)  1.01 (0.26)  0.97 (0.25)  0.95 (0.25)  0.93 (0.24)  0.89 (0.26)
Global  1.18 (0.19)  1.09 (0.20)  1.09 (0.17)  1.10 (0.17)  1.10 (0.17)  1.10 (0.17)  1.09 (0.18)
Table 3. Mean (SD) values of BMD (in g/cm²) in the 7 Gruen zones from baseline to 5 years in the Unique femoral group
Gruen zone  Baseline  3 months  6 months  12 months   24 months  36 months  60 months
1  0.70 (0.11)  0.63 (0.13)  0.64 (0.14)  0.63 (0.14)  0.62 (0.15)  0.59 (0.14)  0.61 (0.19)
2  1.42 (0.27)  1.30 (0.33)   1.29 (0.32)  1.30 (0.36)  1.26 (0.36)  1.21 (0.34)  1.28 (0.32)
3  1.71 (0.26)  1.63 (0.33)  1.65 (0.37)  1.64 (0.32)  1.63 (0.30)  1.61 (0.35)  1.62 (0.27)
4  1.72 (0.21)  1.69 (0.23)  1.67 (0.24)  1.65 (0.25)  1.66 (0.27)  1.59 (0.29)  1.57 (0.31)
5  1.71 (0.20)  1.67 (0.18)  1.69 (0.19)  1.69 (0.20)  1.69 (0.20)  1.66 (0.21)  1.68 (0.24)
6  1.13 (0.25)  1.06 (0.27)  1.06 (0.27)  1.07 (0.27)  1.08 (0.28)  1.03 (0.29)  1.10 (0.34)
7  1.01 (0.21)  0.84 (0.23)  0.81 (0.23)  0.80 (0.24)  0.77 (0.25)  0.72 (0.23)  0.75 (0.27)
Global  1.15 (0.15)  1.07 (0.17)  1.06 (0.17)  1.03 (0.22)  1.04 (0.18)  1.00 (0.17)  1.04 (0.20)414  Acta Orthopaedica 2011; 82 (4): 410–416
Discussion
Dual-energy X-ray absorptiometry (DXA) is regarded as an 
accurate method for detection of small changes in bone min-
eral density (BMD) close to hip arthroplasties (Kiratli et al. 
1992, Cohen and Rushton 1995, Kiratli et al. 1996). In this 
study, DXA measurements showed a difference in baseline 
results  following  insertion  of  the  anatomical ABG-I  stem 
and the customized Unique stem, when data were analyzed 
according to the 7 Gruen zones. We found higher postopera-
tive BMD values in proximal zones 1, 6, and 7 of femurs in 
patients with the ABG-I stem than in the corresponding zones 
of femurs in patients with the Unique stem. The explanation 
for this difference may be found in the way the femurs were 
prepared before inserting the stems. The design of the custom 
stem implies that more bone would be removed from the 
metaphysis during rasping than the amount of bone removed 
during stepwise rasping with the ABG-I broaches. We also 
observed that there was a higher proportion of secondary hip 
arthrosis in the Unique group, compared to the ABG-I group 
(Table 1), but we did not find any difference in postoperative 
BMD when comparing the subgroups of patients according to 
diagnosis (p > 0.17). We therefore believe that the difference 
in baseline results in the proximal zones may be attributed 
to the different ways of preparing and rasping the proximal 
femur. We found a pronounced decline in BMD in the proxi-
mal Gruen zones both in the ABG-I group and the Unique 
group after 2 years; thereafter, there was a tendency of a small 
shift in bone mass between zones from 2 to 5 years. These 
findings correspond to reports from other authors reporting 
on bone loss and remodeling after insertion of cementless 
THRs (Wixson et al. 1997, Rosenthall et al. 1999, Tanzer et 
al. 2001, Venesmaa et al. 2001, Grant et al. 2005, Panisello 
et al. 2009a). There were no significant differences between 
the 2 stems regarding bone loss in the proximal Gruen zones 
at 5 years.
 In Gruen zone 4, on the other hand, the ABG arthroplasty 
gave  better  bone  preservation  than  the  Unique  stem.  The 
ABG-I stem has a grit-blasted surface texture distally, while 
the Unique stem is downscaled distally to prevent distal lock-
ing. The grit-blasted texture of the ABG-I might favor distal 
bone preservation (van der Wal et al. 2008). 
To prevent bone resorption in the upper femur after implan-
tation of a femoral stem, the prevailing theory is to have a 
physiological transfer of loads from the prosthetic head to cor-
tical bone in the metaphysis. The Unique stem has an optimal 
fit to the inner cortical surface in the metaphyseal region, and 
was designed to load the proximal part of the femur in order 
to minimize stress shielding (Aamodt et al. 2001). In fact, in 
vitro analysis of strain on human cadaver femurs has shown 
that cortical strains in the proximal femur are retained after 
insertion of a custom femoral stem to a significantly higher 
degree  than  after  insertion  of  a  standard,  anatomical  stem 
(Aamodt et al. 2001, Østbyhaug et al. 2009). 
The Unique stem has an HA coating extending approxi-
mately 15–20 mm below the tip of the lesser trochanter, which 
may encourage fixation in the distal part of the coated area 
and hence stress shielding in the metaphyseal area (Sumner 
and Galante 1992). This may explain the lower magnitude of 
bone loss in Gruen zones 3 and 5 than in the proximal lateral 
and medial zones. After 5 years, there was bone loss of 1.2% 
in zone 3 and a gain of 1.9% in zone 5, which may indicate 
distal fixation and stress relief in zones 1 and 7. Although it 
has not been shown experimentally or clinically, it is possible 
that the extent of the HA-coating, and thus the area of second-
ary fixation, is more important for the pattern of load transfer 
than the fit and fill of the stem. The limited metaphyseal bone 
loss measured after implantation of ultra-short femoral stems 
supports this hypothesis (Albanese et al. 2009). In order to 
maintain strains in the metaphyseal part of the femur, after 
biological fixation, a stem with a high degree of metaphyseal 
fit and fill should probably not be designed to obtain biologi-
cal fixation below the lesser trochanter. 
Due to the canal-filling design feature of the Unique stem, 
the implant has a large cross-sectional geometry, which makes 
it relatively stiff. Size and stiffness of the femoral implant are 
considered  to  be  important  factors  regarding  bone  remod-
eling around hip arthroplasties, and negative bone remodeling 
is more apparent around larger and stiffer stems (Engh and 
Bobyn 1988, Huiskes et al. 1992, Sumner and Galante 1992, 
Wixson et al. 1997, Skoldenberg et al. 2006). Reduced bone 
loss has been demonstrated around isoelastic, flexible stems 
as compared to titanium alloy arthroplasties (Ang et al. 1997, 
Karrholm et al. 2002). Both the ABG-I stem and the Unique 
stem have gone through some modifications since our study 
was conducted. The second generations of both arthroplast-
ies have smaller metaphyseal volume for similar sizes. Other 
modifications for ABG-II include the use of less stiff titanium 
alloy and polishing of the distal part of the diaphyseal stem 
(Van der Wal et al. 2006, 2008, Herrera et al. 2009). The 
Unique stem has had a proximal porous coating added under 
the HA layer, and the stem distal to the coated area is now 
highly polished (Benum and Aamodt 2010). 
Grant  et  al.  (2005)  compared  the  Unique  stem  with  a 
cemented  arthroplasty  and  published  2-year  DXA  results. 
They reported a greater reduction in BMD around the Unique 
stem compared to the results in our study. In zone 1, we found 
a 13% reduction in BMD after 2 years, as opposed to the 22% 
reduction reported in the study by Grant et al. There was an 
even more pronounced decline in zone 7, with a bone loss of 
24% and 32%, respectively. The results of Grant et al. and 
those in our study revealed a higher degree of proximal bone 
loss than in previous investigations on custom-made implants 
(Martini et al. 1996, Zerahn et al. 1998, Leichtle et al. 2006). 
These  authors  reported  a  reduction  in  proximal  BMD  of 
between 10% and 15% at the end of the third year. Grant et 
al. had a smaller study population: 38 patients as compared to 
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preoperatively, which Rahmy et al. (2004) stated as an impor-
tant factor for prediction of bone loss postoperatively. Since 
we had almost the same distribution regarding age and gender 
of the populations, we do not believe that the two populations 
would have differed in preoperative bone mass.
The bone loss observed did not appear to affect the clinical 
outcome of our patients, which was similar to that in previous 
reports on these stems (Rogers et al. 2003, Herrera et al. 2004, 
Rahmy et al. 2004, Benum and Aamodt 2010). 
As far as we know, no other randomized studies have led to 
5-year DXA results comparing different designs of cement-
less femoral stems. Our study has some limitations. No power 
analysis was performed before the study started. The sample 
size estimate was based on studies in the literature. Rahmy et 
al. (2004) and van der Wal et al. (2008) stated that the preop-
erative BMD was the most important factor for prediction of 
bone loss following a hip arthroplasty. They recommended that 
the patients should be matched for preoperative bone quality 
in randomized studies. In this study, we did not obtain DXA 
measurements of the hip or other skeletal regions before the 
hip arthroplasty. Instead, we used the immediate postoperative 
BMD measurements as baseline values for computation of the 
subsequent changes in periprosthetic bone mass. In addition, 
due to bone resorption, the proximal femur in zone 7 changes 
its contour line and often diminishes. This may make the DXA 
measurement in this zone less accurate. 
The medium- and long-term clinical consequences of the 
proximal bone loss around uncemented stems are uncertain. 
No aseptic loosening has been observed radiologically in large 
series of hips followed prospectively for 7 and 10 years after 
implantation of the Unique stem (Benum and Aamodt 2010). 
The implants used in our study were both stiff, canal-filling 
stems, which may have contributed to negative bone remod-
eling. The extent of the HA layer and the unpolished surface 
of the distal part of the Unique stem may have encouraged 
distal fixation and bone loss in the proximal region. Bone 
remodeling after total hip arthroplasty is affected by several 
different factors, and together with the stress-shielding, bone 
loss around a femoral stem may also occur as a result of an 
inflammatory reaction to wear particles (Schmalzried and Cal- (Schmalzried and Cal-
laghan 1999, Rahmy et al. 2004). Our study illustrates that the 
predictive value of in vitro tests regarding strain distribution 
should not be overestimated. 
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